Anthem Inc (ANTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
87
About the Report
About the Report
Summary
Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers managed healthcare related products and administrative services. The company provides various specialty and insurance products and services including radiology benefit management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small employer, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employee Program (FEP). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), and has license for insurance operations in all the 50 states of the US. Anthem is headquartered in Indianapolis, Indiana, the US.
Anthem Inc (ANTM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Anthem Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10
Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Anthem Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Linkwell Health Raises USD 11 Million In Series C Financing 12
Private Equity 13
LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13
Partnerships 14
Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14
New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 15
Eli Lilly Enters into Research Agreement with Anthem and HealthCore 16
Debt Offering 17
Anthem Raises USD750 Million in Private Placement of Notes Due 2022 17
Anthem Raises USD850 Million in Private Placement of Notes Due 2024 18
Anthem Raises USD1.6 Billion in Private Placement of Notes Due 2027 19
Anthem Raises USD1.4 Billion in Private Placement of Notes Due 2047 20
Anthem Raises USD900 Million in Private Placement of Notes Due 2020 21
WellPoint Completes Private Placement Of Debentures Due 2042 For USD 1.5 Billion 22
WellPoint Completes Public Offering Of Notes Due 2043 For USD 1 Billion 24
WellPoint Completes Public Offering Of Notes Due 2015 For USD 625 Million 26
WellPoint Completes Public Offering Of Notes Due 2018 For USD 625 Million 28
WellPoint Completes Public Offering Of Notes Due 2023 For USD 1 Billion 30
WellPoint Completes Public Offering Of Senior Notes Due 2022 For USD 850 Million 32
WellPoint Completes Public Offering Of Senior Notes Due 2042 For USD 900 Million 33
Acquisition 34
HealthCore Acquires New England Research Institutes (NERI) 34
Anthem Acquires Simply Healthcare 35
WellPoint Completes Acquisition Of Amerigroup For USD 4.9 Billion 36
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 38
Amerigroup Acquires Health Plus From Lutheran Medical Center For USD 85 Million 39
Anthem Inc-Key Competitors 41
Anthem Inc-Key Employees 42
Anthem Inc-Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 46
Financial Announcements 46
Oct 31, 2018: Anthem reports third quarter 2018 results reflecting strengthening operating performance 46
Jul 25, 2018: Anthem reports second quarter 2018 results reflecting strong overall enterprise-wide execution 48
Apr 25, 2018: Anthem Reports First Quarter 2018 Results Reflecting Strong Medical Cost Performance 50
Jan 31, 2018: Anthem Reports Fourth Quarter and Full Year 2017 Results Reflecting Balanced Performance across Its Business Units 52
Oct 25, 2017: Anthem Reports Third Quarter 2017 Results 55
Jul 26, 2017: Anthem Reports Second Quarter 2017 Results 58
Apr 26, 2017: Anthem Reports First Quarter 2017 Results 60
Feb 01, 2017: Anthem Reports Fourth Quarter and Full Year 2016 Results 63
Corporate Communications 64
May 10, 2018: Chief Operating Officer Deepti Jain to Lead IngenioRx 64
Feb 22, 2018: Anthem Board of Directors Names Elizabeth E. Tallett as Independent Chairman of the Board 65
Jan 31, 2018: Anthem Appoints Bahija Jallal As New Director 66
Dec 07, 2017: Anthem's Board Welcomes Antonio Neri as New Director 67
Nov 16, 2017: Anthem Names Greg Poulakos President of Anthem Life & Disability Business 68
Nov 06, 2017: Anthem Announces Key Management Changes 69
Aug 30, 2017: Anthem Names Tomas Orozco President of Medicare East Region 70
Aug 24, 2017: Anthem Names Jacquelyn H. Wolf as Executive Vice President, Chief Human Resources Officer 71
Legal and Regulatory 72
Oct 15, 2018: Anthem Pays OCR USD 16 Million in Record HIPAA Settlement Following Largest U.S. Health Data Breach in History 72
Apr 28, 2017: Anthem Responds to U.S. Court of Appeals Decision on Acquisition of Cigna 73
Feb 09, 2017: Anthem Responds to U.S. District Court's Decision on Acquisition of Cigna 74
Government and Public Interest 75
Sep 25, 2018: NORD Receives Grant from Anthem Foundation for Expansion of Rare Disease Database 75
Sep 20, 2018: March Of Dimes receives USD 1.5 million grant from The Anthem Foundation 76
Sep 05, 2018: National Council on Aging awarded grant from the Anthem Foundation to bring aging mastery to thousands of older adults 77
Sep 07, 2017: Anthem: Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug 78
Aug 23, 2017: Anthem Reaches Goal Two Years Early for Health Plans to Reduce Opioids Filled at Pharmacy by 30 Percent 79
Product News 80
Nov 08, 2017: Anthem Health Plans Play Major Role in Trial to Determine Best Aspirin Dose to Prevent Heart Attacks and Strokes 80
Other Significant Developments 81
Oct 11, 2018: Anthem activates plan to help residents impacted by Hurricane Michael 81
Sep 13, 2018: Anthem activates plan to help residents in states impacted by hurricane florence 82
Jun 12, 2018: Anthem Blue Cross and Blue Shield Adds Decatur County Memorial Hospital to Its Medicare Advantage Provider Network 83
May 22, 2018: Anthem Announces Plans to Remain Headquartered in Indianapolis 84
Oct 18, 2017: Anthem Launches IngenioRx, New Pharmacy Benefits Manager 85
Sep 21, 2017: UniCare Health Plan in West Virginia Takes Action to Help Treat Substance Use Disorder Across the State 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87
List of Figure
List of Figures
Anthem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anthem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Anthem Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anthem Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Anthem Inc, Medical Devices Deals, 2012 to YTD 2018 10
Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Linkwell Health Raises USD 11 Million In Series C Financing 12
LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13
Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14
New England Research Institutes Enters into Research Agreement with National Heart Lung and Blood Institute 15
Eli Lilly Enters into Research Agreement with Anthem and HealthCore 16
Anthem Raises USD750 Million in Private Placement of Notes Due 2022 17
Anthem Raises USD850 Million in Private Placement of Notes Due 2024 18
Anthem Raises USD1.6 Billion in Private Placement of Notes Due 2027 19
Anthem Raises USD1.4 Billion in Private Placement of Notes Due 2047 20
Anthem Raises USD900 Million in Private Placement of Notes Due 2020 21
WellPoint Completes Private Placement Of Debentures Due 2042 For USD 1.5 Billion 22
WellPoint Completes Public Offering Of Notes Due 2043 For USD 1 Billion 24
WellPoint Completes Public Offering Of Notes Due 2015 For USD 625 Million 26
WellPoint Completes Public Offering Of Notes Due 2018 For USD 625 Million 28
WellPoint Completes Public Offering Of Notes Due 2023 For USD 1 Billion 30
WellPoint Completes Public Offering Of Senior Notes Due 2022 For USD 850 Million 32
WellPoint Completes Public Offering Of Senior Notes Due 2042 For USD 900 Million 33
HealthCore Acquires New England Research Institutes (NERI) 34
Anthem Acquires Simply Healthcare 35
WellPoint Completes Acquisition Of Amerigroup For USD 4.9 Billion 36
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 38
Amerigroup Acquires Health Plus From Lutheran Medical Center For USD 85 Million 39
Anthem Inc, Key Competitors 41
Anthem Inc, Key Employees 42
Anthem Inc, Subsidiaries 43
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.